Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × Dexamethasone × Clear all

NCT02424045 2018-09-06

Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma

Phase 2 Completed

Lymphoma, T-Cell